Deal values Syngene at a premium to the recent transaction where Biocon bought back GE Capital's stake.
The firm is expected to file documents for IPO next month.
For Piramal Enterprises this would mark another disengagement from healthcare as a business.
Earlier Intas was planning an IPO to give part exit to ChrysCap.
It counts Ronnie Screwvala as a shareholder.
Congrates Manas. Keep it up. This is B S Yadav from Indo gulf .
Good article. Few comments:
1. Many times "starting a new fund" sounds a good reason for an exit; exit may be...
Why did he leave CG?